The US health regulator is delaying a decision on authorizing Moderna Inc's COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of heart inflammation, the Wall Street Journal reported on Friday, citing people familiar with the matter.
US FDA delays decision on Moderna's COVID-19 vaccine for adolescents
By REUTERS
06/28/2024 01:32 AM
By SHLOMI HELLER
06/27/2024 09:43 PM
By ELI ASHKENAZI
06/27/2024 06:45 PM
By REUTERS
06/27/2024 05:27 PM
By REUTERS
06/27/2024 04:52 PM
By REUTERS
06/27/2024 04:12 PM
By REUTERS
06/27/2024 11:19 AM